Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
2.000
-0.030 (-1.48%)
At close: Nov 4, 2024, 4:00 PM
2.010
+0.010 (0.50%)
After-hours: Nov 4, 2024, 5:37 PM EST
Esperion Therapeutics Employees
Esperion Therapeutics had 240 employees as of December 31, 2023. The number of employees increased by 41 or 20.60% compared to the previous year.
Employees
240
Change (1Y)
41
Growth (1Y)
20.60%
Revenue / Employee
$1,157,450
Profits / Employee
-$410,404
Market Cap
392.45M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ZimVie | 2,600 |
GRAIL | 1,360 |
Sangamo Therapeutics | 405 |
4D Molecular Therapeutics | 147 |
C4 Therapeutics | 145 |
MaxCyte | 143 |
Theravance Biopharma | 99 |
GH Research | 49 |
ESPR News
- 19 hours ago - Esperion to Participate in Upcoming Jefferies London Healthcare Conference - GlobeNewsWire
- 11 days ago - Esperion to Report Third Quarter 2024 Financial Results on November 7 - GlobeNewsWire
- 5 weeks ago - Esperion Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Esperion Secures Additional Commercial and Medicare Formulary Coverage for NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) - GlobeNewsWire
- 2 months ago - Esperion to Participate in Upcoming H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 2 months ago - Esperion Therapeutics: Delivering On Expectations While Navigating Overhangs - Seeking Alpha
- 2 months ago - Esperion Therapeutics: Strategically Positioned To Grow - Seeking Alpha
- 3 months ago - Esperion Therapeutics, Inc. (ESPR) Q2 2024 Earnings Call Transcript - Seeking Alpha